Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXN8XR
|
||||
Drug Name |
[3-Methyl-1-(3-{4-methyl-2-[(quinoline-7-carbonyl)-amino]-pentanoylamino}-4-oxo-pyrrolidin-1-ylmethyl)-butyl]-carbamic acid benzyl ester
|
||||
Synonyms |
CHEMBL350591
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C34H43N5O5
|
||||
Canonical SMILES |
CC(C)C[C@@H](CN1CC(NC(=O)[C@H](CC(C)C)NC(=O)c2ccc3cccnc3c2)C(=O)C1)NC(=O)OCc4ccccc4
|
||||
InChI |
InChI=1S/C34H43N5O5/c1-22(2)15-27(36-34(43)44-21-24-9-6-5-7-10-24)18-39-19-30(31(40)20-39)38-33(42)29(16-23(3)4)37-32(41)26-13-12-25-11-8-14-35-28(25)17-26/h5-14,17,22-23,27,29-30H,15-16,18-21H2,1-4H3,(H,36,43)(H,37,41)(H,38,42)/t27-,29-,30?/m0/s1
|
||||
InChIKey |
DLJDOHHQJSCLFD-CVYBXRIJSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin B | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
WikiPathways | RANKL/RANK Signaling Pathway | ||||
Osteoclast Signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.